St. Louis Jury Returns $70 Million Verdict against Johnson & Johnson and Supplier in Talcum Powder Ovarian Cancer Case
Earlier this month, a jury returned a massive $70 million verdict against Johnson & Johnson and Imerys Talc America in a lawsuit regarding the company’s talcum powder products. The verdict constituted $67.25 million against Johnson & Johnson, $65 million of which represented a punitive damages award. The jury assigned $2.75 million in damages against Imerys Talc America and $2.5 million in punitive damages. Unlike other types of damages, punitive damages are designed to punish a defendant that engages in willful, malicious, and reckless conduct.
The plaintiff, Deborah Giannecchini, a 62-year-old woman, alleged that she used Johnson & Johnson’s baby powder products for over 40 years until she was diagnosed with ovarian cancer in 2013. Based on her treating physicians’ analysis, Mrs. Giannecchini faces an 80 percent chance of dying as a result of ovarian cancer in the next two years. She has also undergone chemotherapy, radiation, and surgery in an attempt to treat her cancer. During the trial, the plaintiff’s lawyer offered evidence suggesting that Johnson & Johnson had been aware of the link between talcum powder and ovarian cancer for three decades through their possession of scientific studies.
The basis of the jury’s conclusion was that Johnson & Johnson should have provided a warning to consumers about the risk of using talcum powder-based products and the potential to develop ovarian cancer.